Phytomedicine, Journal Year: 2024, Volume and Issue: unknown, P. 156041 - 156041
Published: Sept. 1, 2024
Language: Английский
Phytomedicine, Journal Year: 2024, Volume and Issue: unknown, P. 156041 - 156041
Published: Sept. 1, 2024
Language: Английский
Signal Transduction and Targeted Therapy, Journal Year: 2025, Volume and Issue: 10(1)
Published: March 7, 2025
Redox signaling acts as a critical mediator in the dynamic interactions between organisms and their external environment, profoundly influencing both onset progression of various diseases. Under physiological conditions, oxidative free radicals generated by mitochondrial respiratory chain, endoplasmic reticulum, NADPH oxidases can be effectively neutralized NRF2-mediated antioxidant responses. These responses elevate synthesis superoxide dismutase (SOD), catalase, well key molecules like nicotinamide adenine dinucleotide phosphate (NADPH) glutathione (GSH), thereby maintaining cellular redox homeostasis. Disruption this finely tuned equilibrium is closely linked to pathogenesis wide range Recent advances have broadened our understanding molecular mechanisms underpinning dysregulation, highlighting pivotal roles genomic instability, epigenetic modifications, protein degradation, metabolic reprogramming. findings provide foundation for exploring regulation mechanistic basis improving therapeutic strategies. While antioxidant-based therapies shown early promise conditions where stress plays primary pathological role, efficacy diseases characterized complex, multifactorial etiologies remains controversial. A deeper, context-specific signaling, particularly redox-sensitive proteins, designing targeted aimed at re-establishing balance. Emerging small molecule inhibitors that target specific cysteine residues proteins demonstrated promising preclinical outcomes, setting stage forthcoming clinical trials. In review, we summarize current intricate relationship disease also discuss how these insights leveraged optimize strategies practice.
Language: Английский
Citations
4Neuron, Journal Year: 2025, Volume and Issue: 113(1), P. 49 - 70
Published: Jan. 1, 2025
Language: Английский
Citations
3Journal of Clinical Investigation, Journal Year: 2024, Volume and Issue: 134(10)
Published: May 14, 2024
Cerebral small vessel disease (cSVD) encompasses a heterogeneous group of age-related pathologies that affect multiple regions. Disease manifestations range from lesions incidentally detected on neuroimaging (white matter hyperintensities, deep infarcts, microbleeds, or enlarged perivascular spaces) to severe disability and cognitive impairment. cSVD accounts for approximately 25% ischemic strokes the vast majority spontaneous intracerebral hemorrhage is also most important vascular contributor dementia. Despite its high prevalence potentially long therapeutic window, there are still no mechanism-based treatments. Here, we provide an overview recent advances in this field. We summarize data highlighting remarkable continuum between monogenic multifactorial cSVDs involving NOTCH3, HTRA1, COL4A1/A2 genes. Taking vessel-centric view, discuss possible cause-and-effect relationships risk factors, structural functional changes, manifestations, underscoring some major knowledge gaps. Although endothelial dysfunction rightly considered central feature cSVD, contributions smooth muscle cells, pericytes, other cells warrant continued investigation.
Language: Английский
Citations
16Published: Aug. 12, 2024
The triad of vascular impairment, muscle atrophy, and cognitive decline represents critical age-related conditions that significantly impact health. Vascular impairment disrupts blood flow, precipitating mass reduction seen in sarcopenia the neuronal functions characteristic neurodegeneration. Our limited understanding intricate relationships within this hinders accurate diagnosis effective treatment strategies. This review ana-lyzes interrelated mechanisms contribute to these conditions, with a specific focus on ox-idative stress, chronic inflammation, impaired nutrient delivery. aim is understand common pathways involved suggest comprehensive therapeutic approaches. dysfunctions hinder circulation transportation nutrients, resulting sar-copenia characterized by atrophy weakness. dysfunction have negative physical function quality life. Neurodegenerative diseases exhibit comparable pathophysiological affect motor functions. Preventive approaches encompass lifestyle adjustments, addressing oxidative in-flammation, integrated therapies improving muscular well-being. Better links can refine strategies yield better patient out-comes. study emphasizes complex interplay between dysfunction, de-generation, decline, highlighting necessity for multidisciplinary ap-proaches. Advances domain promise improved diagnostic accuracy, more thera-peutic options, enhanced preventive measures, all contributing higher life elderly population.
Language: Английский
Citations
15AJP Heart and Circulatory Physiology, Journal Year: 2024, Volume and Issue: 326(3), P. H689 - H704
Published: Jan. 12, 2024
With advancing age, the cerebral vasculature becomes dysfunctional, and this dysfunction is associated with cognitive decline. However, initiating cause of these age-related cerebrovascular impairments remains incompletely understood. A characteristic feature aging increase in stiffness large elastic arteries. This arterial elevated pulse pressure blood flow pulsatility vasculature. Evidence from both humans rodents supports that increases artery are impairments. These impacts on function wide-ranging include reductions global regional flow, small vessel disease, endothelial cell dysfunction, impaired perivascular clearance. Furthermore, recent findings suggest relationship between may be influenced by genetics, specifically
Language: Английский
Citations
10Current Opinion in Psychiatry, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 22, 2025
Purpose of review Recent advancements in molecular biomarkers and therapeutic options for Alzheimer's disease have brought into focus the need greater progress second most common cause dementia, vascular cognitive impairment dementia (VCID). We examine how study monogenic causes VCID has contributed to understanding its pathophysiology potential biomarker treatment research. findings It is widely accepted that conditions which disrupt cerebral small vessels contribute pathologies including stroke microbleeds, ultimately leading dementia. Among these are a range vessel diseases (SVDs) such as CADASIL, CARASIL, Fabry COL4A-related disorders. Summary This indicates importance furthering research SVDs order gain insight pathomechanisms more broadly. Monogenic easier model than sporadic can serve guide identifying diagnosis, monitoring intervention outcomes.
Language: Английский
Citations
1CNS Neuroscience & Therapeutics, Journal Year: 2025, Volume and Issue: 31(1)
Published: Jan. 1, 2025
ABSTRACT Aims The aim of this study is to investigate the role glymphatic function cerebral autosomal dominant arteriopathy, subcortical infarcts, and leukoencephalopathy (CADASIL), most common monogenic small vessel disease caused by NOTCH3 mutation, explore potential therapeutic strategies improve function. Methods We assessed influx efflux in CADASIL mouse models ( Notch3 R170C ) correlated these findings with brain atrophy patients. also investigated underlying mechanisms impairment, focusing expression AQP4 astrocytic endfeet. Results exhibited both impaired efflux, which impedes waste clearance promotes senescence. In accordance, patients associated perivascular space enlargement, indicating that impairment contributes advanced senescence CADASIL. malfunction attributed diminished endfeet, core mediator activity. Mechanistically, regulated NOTCH3‐RUNX1‐CMYB signaling. Reinforcing astrocytes AAV‐based therapy resumes functions mice, further prevents Conclusion propose reinforcing a promising strategy
Language: Английский
Citations
1Nature Reviews Molecular Cell Biology, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 28, 2025
Language: Английский
Citations
1Progress in Retinal and Eye Research, Journal Year: 2024, Volume and Issue: 101, P. 101271 - 101271
Published: May 11, 2024
Chronic elevation of blood glucose at first causes relatively minor changes to the neural and vascular components retina. As duration hyperglycemia persists, nature extent damage increases becomes readily detectable. While this second, overt manifestation diabetic retinopathy (DR) has been studied extensively, what prevents maximal from very start remains largely unexplored. Recent studies indicate that diabetes (DM) engages mitochondria-based defense during retinopathy-resistant phase, thereby enables retina remain healthy in face hyperglycemia. Such resilience is transient, its deterioration results progressive accumulation retinal damage. The concepts co-emerge with these discoveries set stage for novel intellectual therapeutic opportunities within DR field. Identification biomarkers mediators protection DM-mediated will enable development resilience-based therapies indefinitely delay onset DR.
Language: Английский
Citations
8Frontiers in Aging Neuroscience, Journal Year: 2024, Volume and Issue: 16
Published: Feb. 28, 2024
Sensorineural hearing loss (SNHL) is a category of that often leads to difficulty in understanding speech and other sounds. Auditory system dysfunction, including deafness auditory trauma, results cognitive deficits via neuroplasticity. Cognitive impairment (CI) refers an abnormality the brain’s higher intellectual processes related learning, memory, thinking judgment can lead severe learning memory deficits. Studies have established strong correlation between SNHL CI, but it remains unclear how contributes CI. The purpose this article describe three hypotheses regarding relationship, mainstream load hypothesis, co-morbidity sensory deprivation as well latest research progress each hypothesis.
Language: Английский
Citations
6